Ruoyu Chen
Chief Financial Officer
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Start not stated–2026-05-04
-
Start not stated–2026-05-04
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Gyre Therapeutics, Inc. (GYRE) | Chief Financial Officer | $250,000 | $285,583 |
| 2024 | Gyre Therapeutics, Inc. (GYRE) | Chief Financial Officer | $250,000 | $650,516 |
| 2023 | Gyre Therapeutics, Inc. (GYRE) | Chief Financial Officer | $20,833 | $208,162 |
Recent activity
Earnings-call appearances and filed executive appointments or departures, newest first.